blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2959005

EP2959005 - MEDICAL USE RELATING TO TELOMERE EXTENSION [Right-click to bookmark this link]
Former [2016/01]COMPOUNDS, COMPOSITIONS, METHODS, AND KITS RELATING TO TELOMERE EXTENSION
[2021/21]
StatusNo opposition filed within time limit
Status updated on  12.08.2022
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  03.09.2021
FormerGrant of patent is intended
Status updated on  29.04.2021
FormerExamination is in progress
Status updated on  08.06.2018
Most recent event   Tooltip24.01.2025Change - lapse in a contracting state
State(s) deleted from list of lapses: FI		published on 26.02.2025  [2025/09]
Applicant(s)For all designated states
The Board of Trustees of the Leland Stanford Junior University
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386
Stanford, CA 94305-2038 / US
[2019/38]
Former [2016/01]For all designated states
The Board of Trustees of the Leland Stanford Junior University
Office of Technology Licensing
1705 El Camino Real
Palo Alto, CA 94306 / US
Inventor(s)01 / RAMUNAS, John
425 Olive Street
Menlo Park, California 94025 / US
02 / YAKUBOV, Eduard
2600 Gramercy Street
332
Houston, Texas 77030 / US
03 / BLAU, Helen M.
580 Cotton Street
Menlo Park, California 94025 / US
04 / COOKE, John
Apt. 845
Arcadian Kirby
7550 Kirby Drive
Houston, Texas 77030 / US
 [2016/01]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2016/01]
Application number, filing date14754545.322.02.2014
[2016/01]
WO2014US17867
Priority number, dateUS201361768047P22.02.2013         Original published format: US 201361768047 P
[2016/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014130909
Date:28.08.2014
Language:EN
[2014/35]
Type: A1 Application with search report 
No.:EP2959005
Date:30.12.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 28.08.2014 takes the place of the publication of the European patent application.
[2015/53]
Type: B1 Patent specification 
No.:EP2959005
Date:06.10.2021
Language:EN
[2021/40]
Search report(s)International search report - published on:US28.08.2014
(Supplementary) European search report - dispatched on:EP22.11.2016
ClassificationIPC:A61K38/45, A61K31/7088
[2021/21]
CPC:
A61K31/7088 (EP,IL,US); A61K31/7115 (IL,RU); A61K38/45 (EP,IL,RU,US);
A61P1/04 (EP,IL); A61P1/14 (EP,IL); A61P1/16 (EP,IL);
A61P11/00 (EP,IL); A61P13/00 (EP,IL); A61P13/02 (EP,IL);
A61P19/00 (EP,IL); A61P19/02 (EP,IL); A61P19/08 (EP,IL);
A61P19/10 (EP,IL); A61P25/00 (EP,IL); A61P25/02 (EP,IL);
A61P25/16 (EP,IL); A61P25/18 (EP,IL); A61P25/22 (EP,IL);
A61P25/24 (EP,IL); A61P25/28 (EP,IL); A61P27/00 (EP,IL);
A61P27/02 (EP,IL); A61P27/06 (EP,IL); A61P27/12 (EP,IL);
A61P27/16 (EP,IL); A61P29/00 (EP,IL); A61P3/00 (EP,IL);
A61P3/02 (EP,IL); A61P3/04 (EP,IL); A61P3/10 (EP,IL);
A61P31/00 (EP,IL); A61P31/16 (EP,IL); A61P35/00 (EP,IL);
A61P37/02 (EP,IL); A61P43/00 (EP,IL); A61P7/00 (EP,IL);
A61P9/00 (EP,IL); A61P9/10 (EP,IL); C12N15/52 (IL,RU,US);
C12N9/1276 (EP,IL,RU,US); C12Y207/07049 (EP,IL,RU,US) (-)
Former IPC [2016/51]C12P19/34, A61K38/45
Former IPC [2016/01]C12P19/34
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/01]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:MEDIZINISCHE VERWENDUNG BEZÜGLICH TELOMERVERLÄNGERUNG[2021/21]
English:MEDICAL USE RELATING TO TELOMERE EXTENSION[2021/21]
French:USAGE MÉDICAL LIÉ À L'EXTENSION DE TÉLOMÈRES[2021/21]
Former [2016/01]VERBINDUNGEN, ZUSAMMENSETZUNGEN, VERFAHREN UND KITS BEZÜGLICH TELOMERVERLÄNGERUNG
Former [2016/01]COMPOUNDS, COMPOSITIONS, METHODS, AND KITS RELATING TO TELOMERE EXTENSION
Former [2016/01]COMPOSÉS, COMPOSITIONS, PROCÉDÉS, ET KITS LIÉS À L'EXTENSION DE TÉLOMÈRES
Entry into regional phase22.09.2015National basic fee paid 
22.09.2015Search fee paid 
22.09.2015Designation fee(s) paid 
22.09.2015Examination fee paid 
Examination procedure22.09.2015Examination requested  [2015/53]
19.06.2017Amendment by applicant (claims and/or description)
12.06.2018Despatch of a communication from the examining division (Time limit: M04)
22.10.2018Reply to a communication from the examining division
26.09.2019Despatch of a communication from the examining division (Time limit: M07)
08.05.2020Reply to a communication from the examining division
18.01.2021Date of oral proceedings
02.02.2021Despatch of a communication from the examining division (Time limit: M02)
02.02.2021Minutes of oral proceedings despatched
12.04.2021Reply to a communication from the examining division
30.04.2021Communication of intention to grant the patent
27.08.2021Fee for grant paid
27.08.2021Fee for publishing/printing paid
27.08.2021Receipt of the translation of the claim(s)
Divisional application(s)EP21200777.7  / EP3988112
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.06.2018
Opposition(s)07.07.2022No opposition filed within time limit [2022/37]
Fees paidRenewal fee
22.02.2016Renewal fee patent year 03
27.02.2017Renewal fee patent year 04
26.02.2018Renewal fee patent year 05
26.02.2019Renewal fee patent year 06
26.02.2020Renewal fee patent year 07
22.02.2021Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipEE06.10.2021
MK06.10.2021
SK06.10.2021
SM06.10.2021
IS06.02.2022
[2025/09]
Former [2024/22]EE06.10.2021
FI06.10.2021
MK06.10.2021
SK06.10.2021
SM06.10.2021
IS06.02.2022
Former [2022/36]EE06.10.2021
FI06.10.2021
SK06.10.2021
SM06.10.2021
IS06.02.2022
Former [2022/34]EE06.10.2021
FI06.10.2021
SM06.10.2021
IS06.02.2022
Former [2022/33]FI06.10.2021
SM06.10.2021
IS06.02.2022
Former [2022/25]FI06.10.2021
IS06.02.2022
Former [2022/22]FI06.10.2021
Documents cited:Search[X] WO2011130624  (IMMUNE DISEASE INST INC et al.) [X] 1-6,9,12,13 * paragraph [0341]; claims 56-66 *
International search[Y] US8323975  (KOOL ERIC T et al.) [Y]
 [Y] US2011143397  (KARIKO KATALIN et al.) [Y]
 [Y]   GREIDER, CW ET AL.: "Telomeres, Telomerase and Senescence.", BIOESSAYS., vol. 12, no. 8, August 1990 (1990-08-01), pages 363 - 369, XP055278069 [Y]

DOI:   http://dx.doi.org/10.1002/bies.950120803
 [Y]   KARIKO, K ET AL.: "Incorporation Of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity And Biological Stability.", MOLECULAR THERAPY., vol. 16, 2008, pages 1833 - 1840, XP002598556 [Y]

DOI:   http://dx.doi.org/10.1038/mt.2008.200
Examination  BRUNO BERNARDES DE JESUS ET AL: "Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer : TERT alone extends lifespan of adult/old mice", EMBO MOLECULAR MEDICINE, vol. 4, no. 8, 15 May 2012 (2012-05-15), Weinheim, pages 691 - 704, XP055384661, ISSN: 1757-4676, DOI: 10.1002/emmm.201200245

DOI:   http://dx.doi.org/10.1002/emmm.201200245
   VIRGINIA BOCCARDI ET AL: "Telomerase gene therapy: a novel approach to combat aging : Telomerase gene therapy", EMBO MOLECULAR MEDICINE, vol. 4, no. 8, 1 August 2012 (2012-08-01), Weinheim, pages 685 - 687, XP055481726, ISSN: 1757-4676, DOI: 10.1002/emmm.201200246

DOI:   http://dx.doi.org/10.1002/emmm.201200246
by applicantUS5583016
 US6166178
 WO2011130624
 US2009286852
 US2011143397
 WO2012009682
   ARTANDIDEPINHO, CARCINOGENESIS, vol. 31, 2010, pages 9 - 18
   O'SULLIVANKARL SEDER, NAT. REV. MOL. CELL BIOL., vol. 11, 2010, pages 171 - 181
   CALADO ET AL., LEUKEMIA, vol. 26, 2012, pages 700 - 707
   BROUILETTE ET AL., ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, vol. 23, 2003, pages 842 - 846
   ALTER ET AL., BLOOD, vol. 113, 2009, pages 6549 - 6557
   WENTZENSEN ET AL., CANCER EPIDEMIOL. BIOMARKERS PREV., vol. 20, 2011, pages 1238 - 1250
   SACCO ET AL., CELL, vol. 143, 2010, pages 1059 - 1071
   CIRC. RES., vol. 89, 2001, pages 793 - 798
   PEREZ-RIVERO ET AL., CIRCULATION, vol. 114, 2006, pages 309 - 317
   MOHSIN ET AL., JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY DOI:10.1016/J.JACC.2012.04.0474, 2012
   HARLEY ET AL., REJUVENATION RESEARCH, vol. 14, 2011, pages 45 - 56
   BODNAR ET AL., SCIENCE, vol. 279, 1998, pages 349 - 352
   BERNARDES DE JESUS B ET AL., EMBO MOL MED, vol. 4, no. 8, August 2012 (2012-08-01), pages 685 - 704
   CIFUENTES-ROJASSHIPPEN, MUTAT. RES., vol. 730, 2012, pages 59 - 67
   VON ZGLINICKI ET AL.: "Laboratory Investigation", JOURNAL OF TECHNICAL METHODS AND PATHOLOGY, vol. 80, 2000, pages 1739 - 1747
   TESTA ET AL., DIABETIC MEDICINE, vol. 28, 2011, pages 1388 - 1394
   BLACKBURN ET AL., CANCER PREVENTION RESEARCH, vol. 3, 2010, pages 394 - 402
   STERNBRYAN, CYTOGENETIC AND GENOME RESEARCH, vol. 122, 2008, pages 243 - 254
   TAKUBO ET AL., GERIATR GERONTOL INT, vol. 10, 2010, pages 197 - 206
   SAHIN ET AL., NATURE, vol. 470, 2011, pages 359 - 365
   SAEBE-LARSSEN ET AL., J. IMMUNOL. METHODS, vol. 259, 2002, pages 191 - 203
   CONG ET AL., MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, vol. 66, 2002, pages 407 - 425
   YOUNG ET AL., J. BIOL. CHEM., vol. 278, 2003, pages 19904 - 19908
   PERRAULT ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 335, 2005, pages 925 - 936
   KARIKO ET AL., IMMUNITY, vol. 23, 2005, pages 165 - 175
   ALVAREZ-ERVITI ET AL., NATURE BIOTECHNOLOGY, vol. 29, 2011, pages 341 - 345
   AUTEXIERLUE, ANNU REV BIOCHEM, vol. 75, 2006, pages 493 - 517
   MEYERSON ET AL., CELL, vol. 90, 1997, pages 785 - 795
   NAKAMURA ET AL., SCIENCE, vol. 277, 1997, pages 955 - 959
   WICK ET AL., GENE, vol. 232, 1999, pages 97 - 106
   "NCBI", Database accession no. XP_004017220.1
   FATH ET AL., PLOS ONE, vol. 6, 2011, pages 3
   LAKHALWOOD, BIOESSAYS: NEWS AND REVIEWS IN MOLECULAR, CELLULAR AND DEVELOPMENTAL BIOLOGY, vol. 33, 2011, pages 737 - 741
   MIZRAK ET AL., MOLECULAR THERAPY, vol. 21, 2013, pages 101 - 108
   O'DOHERTY ET AL., IMMUNOLOGY, vol. 82, 1994, pages 487 - 493
   ARMANIOS, ANN. REV. GENOMICS HUM. GENET., vol. 10, 2009, pages 45 - 61
   ARMANIOS, ANNU. REV. GENOMICS HUM. GENET., vol. 10, 2009, pages 45 - 61
   KIMURA ET AL., NAT PROTOC, vol. 5, 2010, pages 1596 - 607
   YI ET AL., NUCL. ACIDS RES., vol. 29, 2001, pages 4818 - 4825
   BLACKBURN ET AL., CANCER PREV RES (PHILA), vol. 3, 2010, pages 394 - 402
   MOHSIN ET AL., JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012
   KARIKO ET AL., NUCLEIC ACIDS RES., vol. 39, 2011, pages el42
   HARLEY ET AL., REJUVENATION RES, vol. 14, 2011, pages 45 - 56
   DING ET AL., CELL, vol. 148, 2012, pages 896 - 907
   YAKUBOV ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 394, 2010, pages 189 - 193
   KORMANN ET AL., NAT. BIOTECHNOL., vol. 29, 2011, pages 154 - 157
   SAEBOE-LARSSEN ET AL., JOURNAL OF IMMUNOLOGICAL METHODS, vol. 259, 2002, pages 191 - 203
   WYATT: "Ph.D. Thesis", 2009, UNIVERSITY OF CALGARY, article "Structure-Function Analysis of the Human Telomerase Reverse Transcriptase"
   VON ZGLINICKI ET AL., FREE RADIC. BIOL. MED., vol. 28, 2000, pages 64 - 74
   AHMED ET AL., J. CELL. SCI., vol. 121, 2008, pages 1046 - 1053
   WU ET AL., CYTOTECHNOLOGY, vol. 49, 2005, pages 95 - 107
   COUNTER ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 95, 1998, pages 14723 - 14728
   CIFUENTES-ROJAS ET AL., MUTAT. RES. DOI:10.1016/J.MRFMMM.2011.10.003, 2011
   BRITT-COMPTON ET AL., FEBS LETT, vol. 583, 2009, pages 3076 - 3080
   SITTE ET AL., FREE RADIC. BIOL. MED., vol. 24, 1998, pages 885 - 893
   MACKENZIE ET AL., EXP. CELL RES., vol. 259, 2000, pages 336 - 350
   LANSDORP ET AL., HUM. MOL. GENET., vol. 5, 1996, pages 685 - 691
   MARTENS ET AL., NAT. GENET., vol. 18, 1998, pages 76 - 80
   ALLSOPP, R. C. ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 89, 1992, pages 10114 - 10118
   PARK ET AL., NATURE, vol. 460, 2009, pages 66 - 72
   LAKHALWOOD, BIOESSAYS, vol. 33, 2011, pages 737 - 741
   DIMRI ET AL., PROC. NAT'L ACAD. SCI. USA, vol. 92, 1995, pages 9363 - 7
   WEBSTERBLAU, SOMAT CELL MOL GENET, vol. 16, 1990, pages 557 - 565
   HAYFLICKMOORHEAD, EXP CELL RES., vol. 25, 1961, pages 585 - 621
   YAKUBOV ET AL., BIOCHEM BIOPHYS RES COMMUN, vol. 394, 2010, pages 189 - 193
   AHMED ET AL., J CELL SCI, vol. 121, 2008, pages 1046 - 1053
   YI ET AL., NUCLEIC ACIDS RES, vol. 29, 2001, pages 4818 - 4825
   CIFUENTES-ROJASSHIPPEN, MUTATRES, 18 October 2011 (2011-10-18)
   YI ET AL., NUCLEIC ACIDS RES., vol. 29, 2001, pages 4818 - 4825
   KABNICKHOUSMAN, MOL CELL BIOL, vol. 8, 1988, pages 3244 - 3250
   HOLT ET AL., PROC NATL ACAD SCI USA., vol. 94, 1997, pages 10687 - 10692
   XU ET AL., BR J CANCER, vol. 80, 1999, pages 1156 - 1161
   ZHU ET AL., AGING CELL, vol. 6, 2007, pages 515 - 523
   CRISTOFALOKRITCHEVSKY, MED EXP INT J EXP MED., vol. 19, 1969, pages 313 - 320
   DIMRI ET AL., PROC NATL ACAD SCI USA., vol. 92, 1995, pages 9363 - 9367
   CRISTOFALO, MECH AGEING DEV, vol. 125, 2004, pages 827 - 848
   LAWLESS ET AL., EXP GERONTOL, vol. 45, 2010, pages 772 - 778
   BINET ET AL., CANCER RES., vol. 69, 2009, pages 9183 - 9191
   ALLSOPP ET AL., PROC NATL ACAD SCI USA., vol. 89, 1992, pages 10114 - 10118
   LE ET AL., CELL STEM CELL, 19 November 2013 (2013-11-19)
   ZIMMERMANNMARTENS, CELL TISSUE RES, vol. 331, 2008, pages 79 - 90
   MOHSIN, CIRC RES, vol. 113, 2013, pages 1169 - 1179
   GILBERT ET AL., SCIENCE, vol. 329, 2010, pages 1078 - 1081
   WANG ET AL., CELL RES, vol. 22, 2012, pages 757 - 768
   MOURKIOTI ET AL., NAT CELL BIOL, vol. 15, 2013, pages 895 - 904
   LOPEZ-OTIN ET AL., CELL, vol. 153, 2013, pages 1194 - 1217
   KORMANN ET AL., NAT BIOTECHNOL., vol. 29, 2011, pages 154 - 157
   COUNTER ET AL., PROC NATL ACAD SCI USA., vol. 95, 1998, pages 14723 - 14728
   CAWTHON, NUCLEIC ACIDS RES., vol. 30, no. 10, 2002, pages e47
   CAWTHON, NUCLEIC ACIDS RES., vol. 37, no. 3, 2009, pages e21
   UNTERGASSER ET AL., NUCLEIC ACIDS RES., vol. 40, 2012, pages ell5
   GREBER ET AL., EMBO J., vol. 30, 2011, pages 4874 - 4884
   KORMANN ET AL., NATURE BIOTECHNOLOGY, vol. 29, 2012, pages 154 - 157
   KARIKO ET AL., MOLECULAR THERAPY, vol. 20, 2012, pages 948 - 93
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.